Mosanna is a Swiss Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. We carefully select innovative medicines for further development using the best contract research organisations in the specific specialised field. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients.
Location: Switzerland, Basel-Landschaft, Münchenstein
Employees: 1-10
Total raised: $80M
Founded date: 2022
Investors 3
| Date | Name | Website |
| 09.06.2025 | Forbion | forbion.co... |
| 25.03.2024 | VentureLab | venturelab... |
| - | High-Tech ... | htgf.de |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.06.2025 | Series A | $80M | Forbion |
Mentions in press and media 14
| Date | Title | Description |
| 13.06.2025 | Top 10 Startup and Tech Funding News for the Week Ending June 13, 2025 | It’s Friday, June 13, 2025 — and we’re closing the week with a loaded lineup of tech funding deals that show no signs of investor fatigue. From multibillion-dollar strategic bets to stealthy AI sales startups, today’s snapshot reveals where... |
| 10.06.2025 | Mosanna Therapeutics: A Breath of Fresh Air in Sleep Apnea Treatment | In the realm of healthcare, innovation often emerges from the shadows of necessity. Mosanna Therapeutics, a biotech company based in Redwood City, California, is stepping into the spotlight with a groundbreaking approach to treating obstruc... |
| 10.06.2025 | Mosanna Therapeutics raises USD 80 million to advance sleep apnea nasal spray | Mosanna Therapeutics, the clinical-stage biotech company headquartered in Basel, is pioneering a pharmaceutical solution for sleep apnea patients with MOS118, a nasal spray administered at nighttime that helps restore the body’s natural ai... |
| 09.06.2025 | Mosanna Therapeutics Raises $80M in Series A Funding | David Weber, Ph.D., President and Chief Executive Officer at Mosanna Therapeutics Mosanna Therapeutics, a Redwood City, CA-based biotech company which which specializes in treatments of obstructive sleep apnea (OSA), raised $80M in Series A... |
| 09.06.2025 | Top 10 Startup and Tech Funding News – June 9, 2025 | It’s Monday, June 9, 2025. Hope you had a great weekend. We’re back with your daily tech funding roundup, tracking where capital is flowing and which startups are laying the groundwork for what’s next. Today’s deals span AI coding assistant... |
| 09.06.2025 | Forbion co-leads $80 Million Series A Financing in Mosanna Therapeutics to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea | Naarden, The Netherlands – June 9, 2025 – Forbion, a leading venture capital firm with deep biotech expertise in Europe and the US announces that it has co-led an $80 Million Series A financing in Mosanna Therapeutics, a biotech company ret... |
| 09.06.2025 | EQT Life Sciences Leads USD 80 Million Series A Funding Round in Mosanna Therapeutics to Advance Sleep Apnea Nasal Spray | EQT Life Sciences Leads USD 80 Million Series A Funding Round in Mosanna Therapeutics to Advance Sleep Apnea Nasal Spray Mon, Jun 09, 2025 16:15 CET Report this content Series A Funding will be used to advance Mosanna’s nasal spray therapy ... |
| 09.06.2025 | Mosanna Therapeutics Launches with $80M | REDWOOD CITY, CA, Mosanna Therapeutics, a biotech company rethinking treatment of obstructive sleep apnea, announced the close of $80 million in Series A funding. >> Click here for more funding data on Mosanna Therapeutics >> T... |
| 19.04.2023 | Ten biotech startups head to Boston | |
| 12.04.2023 | Mosanna Therapeutics Announces a Seed Extension Financing Round to Complete Preparations to Enter the Clinic with MOS-118 in Metabolic Obstructive Sleep Apnea | April 11, 2023 |
Show more